Hemispherx Biopharma (HEB), myTomorrows Enter Early Access Program Agreement

August 10, 2015 8:38 AM EDT Send to a Friend
Hemispherx Biopharma (NYSE: HEB) has executed an agreement with Impatients, N.V., a Netherlands based company doing business as myTomorrows, for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login